2009年囊性纤维化的最新进展 - Suppr

Suppr

超能文献

Update in cystic fibrosis 2009.

作者信息

Mogayzel Peter J, Flume Patrick A

机构信息

Department of Pediatrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

出版信息

Am J Respir Crit Care Med. 2010 Mar 15;181(6):539-44. doi: 10.1164/rccm.200912-1943UP.

DOI:10.1164/rccm.200912-1943UP

PMID:20208039

Abstract

摘要

相似文献

Update in cystic fibrosis 2009.

Am J Respir Crit Care Med. 2010 Mar 15;181(6):539-44. doi: 10.1164/rccm.200912-1943UP.

Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Expert Rev Anti Infect Ther. 2011 Nov;9(11):967-73. doi: 10.1586/eri.11.131.

Inhaled aztreonam.

Nat Rev Drug Discov. 2010 May;9(5):357-8. doi: 10.1038/nrd3170.

Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).

J Antimicrob Chemother. 2011 Oct;66(10):2398-404. doi: 10.1093/jac/dkr303. Epub 2011 Jul 22.

Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.

Int J Antimicrob Agents. 2005 Mar;25(3):193-7. doi: 10.1016/j.ijantimicag.2004.11.009.

[Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].

Rev Mal Respir. 1991;8(2):263.

Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

Environ Microbiol. 2010 May;12(5):1293-303. doi: 10.1111/j.1462-2920.2010.02173.x. Epub 2010 Feb 23.

Pseudomonas aeruginosa and the airways disease of cystic fibrosis.

Clin Chest Med. 1988 Dec;9(4):679-89.

[Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].

Rev Mal Respir. 2010 May;27(5):449-56. doi: 10.1016/j.rmr.2010.03.015. Epub 2010 Apr 28.

Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.

J Cyst Fibros. 2014 Jan;13(1):116-7. doi: 10.1016/j.jcf.2013.08.003. Epub 2013 Sep 7.

引用本文的文献

Update in Cystic Fibrosis 2018.

Am J Respir Crit Care Med. 2019 May 15;199(10):1188-1194. doi: 10.1164/rccm.201902-0310UP.

Augmentation of CFTR maturation by S-nitrosoglutathione reductase.

Am J Physiol Lung Cell Mol Physiol. 2016 Feb 1;310(3):L263-70. doi: 10.1152/ajplung.00269.2014. Epub 2015 Dec 4.

Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair.

Am J Physiol Cell Physiol. 2014 May 1;306(9):C819-30. doi: 10.1152/ajpcell.00168.2013. Epub 2014 Feb 5.

Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics.

Clin Transl Allergy. 2012 Jun 14;2(1):10. doi: 10.1186/2045-7022-2-10.

Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1619-24. doi: 10.1073/pnas.1108464109. Epub 2012 Jan 17.

Hepatobiliary and pancreatic imaging in children-techniques and an overview of non-neoplastic disease entities.

Pediatr Radiol. 2011 Jan;41(1):55-75. doi: 10.1007/s00247-010-1858-5. Epub 2010 Oct 22.

Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin.

Mucosal Immunol. 2011 Mar;4(2):158-71. doi: 10.1038/mi.2010.62. Epub 2010 Oct 20.

Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis.

Curr Opin Pulm Med. 2010 Nov;16(6):591-7. doi: 10.1097/MCP.0b013e32833f1d00.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Update in cystic fibrosis 2009.

作者信息

Mogayzel Peter J, Flume Patrick A

机构信息

Department of Pediatrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

出版信息

Am J Respir Crit Care Med. 2010 Mar 15;181(6):539-44. doi: 10.1164/rccm.200912-1943UP.

DOI:10.1164/rccm.200912-1943UP

PMID:20208039

Abstract

摘要

相似文献

Update in cystic fibrosis 2009.

Am J Respir Crit Care Med. 2010 Mar 15;181(6):539-44. doi: 10.1164/rccm.200912-1943UP.

Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Expert Rev Anti Infect Ther. 2011 Nov;9(11):967-73. doi: 10.1586/eri.11.131.

Inhaled aztreonam.

Nat Rev Drug Discov. 2010 May;9(5):357-8. doi: 10.1038/nrd3170.

Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).

J Antimicrob Chemother. 2011 Oct;66(10):2398-404. doi: 10.1093/jac/dkr303. Epub 2011 Jul 22.

Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.

Int J Antimicrob Agents. 2005 Mar;25(3):193-7. doi: 10.1016/j.ijantimicag.2004.11.009.

[Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].

Rev Mal Respir. 1991;8(2):263.

Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

Environ Microbiol. 2010 May;12(5):1293-303. doi: 10.1111/j.1462-2920.2010.02173.x. Epub 2010 Feb 23.

Pseudomonas aeruginosa and the airways disease of cystic fibrosis.

Clin Chest Med. 1988 Dec;9(4):679-89.

[Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].

Rev Mal Respir. 2010 May;27(5):449-56. doi: 10.1016/j.rmr.2010.03.015. Epub 2010 Apr 28.

Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.

J Cyst Fibros. 2014 Jan;13(1):116-7. doi: 10.1016/j.jcf.2013.08.003. Epub 2013 Sep 7.

引用本文的文献

Update in Cystic Fibrosis 2018.

Am J Respir Crit Care Med. 2019 May 15;199(10):1188-1194. doi: 10.1164/rccm.201902-0310UP.

Augmentation of CFTR maturation by S-nitrosoglutathione reductase.

Am J Physiol Lung Cell Mol Physiol. 2016 Feb 1;310(3):L263-70. doi: 10.1152/ajplung.00269.2014. Epub 2015 Dec 4.

Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair.

Am J Physiol Cell Physiol. 2014 May 1;306(9):C819-30. doi: 10.1152/ajpcell.00168.2013. Epub 2014 Feb 5.

Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics.

Clin Transl Allergy. 2012 Jun 14;2(1):10. doi: 10.1186/2045-7022-2-10.

Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1619-24. doi: 10.1073/pnas.1108464109. Epub 2012 Jan 17.

Hepatobiliary and pancreatic imaging in children-techniques and an overview of non-neoplastic disease entities.

Pediatr Radiol. 2011 Jan;41(1):55-75. doi: 10.1007/s00247-010-1858-5. Epub 2010 Oct 22.

Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin.

Mucosal Immunol. 2011 Mar;4(2):158-71. doi: 10.1038/mi.2010.62. Epub 2010 Oct 20.

Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis.

Curr Opin Pulm Med. 2010 Nov;16(6):591-7. doi: 10.1097/MCP.0b013e32833f1d00.